Diagnóstico genético de fibrosis quística mediante la técnica de desnaturalización de ADN a alta resolución (HRM)

Cystic Fibrosis Mutation Database. US Cystic Fibrosis Foundation. Toronto. 25/4/2011 [consultado 30 May 2015]. Disponible en: http://www.genet.sickkids.on.ca Boucher R. C. Fibrosis quística. En: Harrison-Braunwald <Ed.> Principios de Medicina Interna. 15. ed. Madrid: Harrison-Braunwald McGraw-Hill Companies, Inc. 1999 Cystic Fibrosis Foundation. Patient Registry 2013. Annual report. Bethesma, Maryland. Cystic Fibrosis Foundation [consultado 30 May 2015]. Disponible en: https://www.cff.org/2013_CFF_Patient_Registry_Annual_Data_Report.pdf Davis PM. Cystic fibrosis since 1938. Am J Respir Crit Care Med. 2006; 1;173(5):475-82. Publicación electrónica 2005 26 Ago. Revisión. Del Ciampo, 2015, Early manifestations of cystic fibrosis in a premature patient with complex meconium ileus at birth, Rev Paul Pediatr., 33, 241, 10.1016/j.rpped.2014.12.004 Wilcken, 2003, Newborn screening methods for cystic fibrosis, Paediatr Respir Rev., 4, 272, 10.1016/S1526-0542(03)00084-8 Langen AV, Dompeling E, Yntema JB, Tiddens H, Loeber G, Dankert-Roelse J. Clinical evaluation of the Nanoduct sweat test system in the diagnosis of cystic fibrosis after newborn screening. Eur J Pediatr. 2015 Feb 13. [Publicación electrónica]. Gundry, 2003, Amplicon melting analysis with labeled primers: a closed-tube method for differentiating homozygotes and heterozygotes, Clin Chem., 49, 396, 10.1373/49.3.396 Wittwer, 2003, High-resolution genotyping by amplicon melting analysis using LCGreen, Clin Chem., 49, 853, 10.1373/49.6.853 Bombieri C, Claustres M, De Boeck K, Derichs N, Dodge J, Girodon E, et al. Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros. 2011;10 Suppl 2:S86-102. Farrell, 2008, Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report, J Pediatr., 153, S4, 10.1016/j.jpeds.2008.05.005 Primer3:WWW primer tool. Steve Rozen, Helen J. Skaletsky.Whitehead Institute for Biomedical Research [consultado 30 May 2015]. Disponible en: http://biotools.umassmed.edu/bioapps/primer3_www.cgi Oligo Analyzer 3.1. IDT. Integrated DNA Technologies. 2015 [consultado 30 May 2015]. Disponible en: https://eu.idtdna.com/calc/analyzer SNPCheck National Genetic Reference Laboratory. Manchester. 8/5/2014 [consultado 30 May 2015]. Disponible en: https://secure.ngrl.org.uk/SNPCheck/snpcheck Audrezet, 2008, Validation of high-resolution DNA melting analysis for mutation scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, J Mol Diagn., 10, 424, 10.2353/jmoldx.2008.080056 Bobadilla, 2002, Cystic fibrosis: a worldwide analysis of CFTR mutations-correlation with incidence data and application to screening, Hum Mutat., 19, 575, 10.1002/humu.10041 Alonso, 2007, Spectrum of mutations in the CFTR gene in cystic fibrosis patients of Spanish ancestry, Ann Hum Genet., 71, 194, 10.1111/j.1469-1809.2006.00310.x Trujillano, 2013, Next generation diagnostics of cystic fibrosis and CFTR-related disorders by targeted multiplex high-coverage resequencing of CFTR, J Med Genet., 50, 455, 10.1136/jmedgenet-2013-101602